Andrew Crowe

1.5k total citations
41 papers, 1.1k citations indexed

About

Andrew Crowe is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Nutrition and Dietetics. According to data from OpenAlex, Andrew Crowe has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Pediatrics, Perinatology and Child Health and 8 papers in Nutrition and Dietetics. Recurrent topics in Andrew Crowe's work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Trace Elements in Health (7 papers). Andrew Crowe is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Trace Elements in Health (7 papers). Andrew Crowe collaborates with scholars based in Australia, United Kingdom and Malaysia. Andrew Crowe's co-authors include Evan H. Morgan, Michel Lemaire, Eve M. Taylor, Jeff Hughes, Armin Bruelisauer, Cameron Wright, Delia J. Nelson, Connie Jackaman, Harin Karunajeewa and Madhu Page‐Sharp and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Nutrition.

In The Last Decade

Andrew Crowe

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Crowe Australia 18 333 254 214 207 166 41 1.1k
R. M. Weinshilboum United States 25 198 0.6× 33 0.1× 280 1.3× 849 4.1× 64 0.4× 65 1.8k
Hideyuki Motohashi Japan 18 944 2.8× 75 0.3× 523 2.4× 349 1.7× 20 0.1× 43 1.5k
Marvin B. Cohen United States 18 367 1.1× 53 0.2× 36 0.2× 363 1.8× 94 0.6× 53 1.1k
Donna J. Buckley United States 26 548 1.6× 97 0.4× 197 0.9× 713 3.4× 23 0.1× 58 1.8k
Petra Arndt Germany 13 848 2.5× 99 0.4× 432 2.0× 382 1.8× 21 0.1× 17 1.4k
Lori A. Plum United States 19 142 0.4× 536 2.1× 192 0.9× 373 1.8× 28 0.2× 83 2.2k
Cathal McCarthy Ireland 20 54 0.2× 103 0.4× 446 2.1× 402 1.9× 37 0.2× 51 1.5k
Alessandro Fulgenzi Italy 22 72 0.2× 123 0.5× 17 0.1× 313 1.5× 56 0.3× 45 1.2k
Ofer Spiegelstein United States 19 66 0.2× 67 0.3× 320 1.5× 305 1.5× 34 0.2× 60 1.2k
Francesc González‐Sastre Spain 26 167 0.5× 148 0.6× 60 0.3× 699 3.4× 58 0.3× 61 2.1k

Countries citing papers authored by Andrew Crowe

Since Specialization
Citations

This map shows the geographic impact of Andrew Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Crowe more than expected).

Fields of papers citing papers by Andrew Crowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Crowe. The network helps show where Andrew Crowe may publish in the future.

Co-authorship network of co-authors of Andrew Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Crowe. A scholar is included among the top collaborators of Andrew Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Crowe. Andrew Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Crowe, Andrew, et al.. (2024). Nudging down residential burglaries: A randomized control trial. Policing A Journal of Policy and Practice. 18. 1 indexed citations
3.
Crowe, Andrew, et al.. (2021). Checkpoint: An innovative Programme to navigate people away from the cycle of reoffending – A randomised control trial evaluation. The Police Journal Theory Practice and Principles. 95(3). 562–589. 6 indexed citations
4.
5.
Page‐Sharp, Madhu, et al.. (2016). The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation. PLoS ONE. 11(4). e0152677–e0152677. 21 indexed citations
6.
Crowe, Andrew, et al.. (2015). The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport. Pharmazie in unserer Zeit. 70(12). 798–803. 1 indexed citations
7.
Crowe, Andrew, et al.. (2013). Distribution of the single nucleotide polymorphism C3435T of MDR1 gene among people in Western Australia, Australia. International Journal of Pharmacy and Pharmaceutical Sciences. 5(4). 470–473. 3 indexed citations
8.
Crowe, Andrew & Jeffrey A. Keelan. (2012). Development of a Model for Functional Studies of ABCG2 (Breast Cancer Resistance Protein) Efflux Employing a Standard BeWo Clone (B24). Assay and Drug Development Technologies. 10(5). 476–484. 4 indexed citations
9.
Mackay, M. F., et al.. (2012). Attitudes of medical imaging technologists on use of gonad shielding in general radiography. 59(2). 35–39. 16 indexed citations
10.
Crowe, Andrew, et al.. (2012). P‐glycoprotein expression in Helicobacter pylori‐positive patients: The influence of MDR1 C3435T polymorphism. Journal of Digestive Diseases. 13(8). 414–420. 12 indexed citations
11.
Crowe, Andrew, et al.. (2012). Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux. Toxicology and Applied Pharmacology. 260(3). 294–302. 45 indexed citations
12.
Crowe, Andrew. (2011). The role of P-glycoprotein and breast cancer resistance protein (BCRP) in bacterial attachment to human gastrointestinal cells. Journal of Crohn s and Colitis. 5(6). 531–542. 10 indexed citations
13.
Crowe, Andrew & Cameron Wright. (2011). The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers. Xenobiotica. 42(6). 538–549. 26 indexed citations
14.
Hughes, Jeff & Andrew Crowe. (2010). Inhibition of P-glycoprotein–Mediated Efflux of Digoxin and Its Metabolites by Macrolide Antibiotics. Journal of Pharmacological Sciences. 113(4). 315–324. 43 indexed citations
15.
Crowe, Andrew, et al.. (2003). Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport. Toxicology and Applied Pharmacology. 193(1). 127–137. 22 indexed citations
16.
Crowe, Andrew, Paul R. Lockman, Thomas J. Abbruscato, & David D. Allen. (2002). Novel Choline Transport Characteristics in Caco-2 Cells. Drug Development and Industrial Pharmacy. 28(7). 773–781. 10 indexed citations
17.
Crowe, Andrew. (2002). The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. European Journal of Pharmacology. 440(1). 7–16. 43 indexed citations
18.
Crowe, Andrew & Michel Lemaire. (1998). In Vitro and In Situ Absorption of SDZ-RAD Using a Human Intestinal Cell Line (Caco-2) and a Single Pass Perfusion Model in Rats: Comparison with Rapamycin. Pharmaceutical Research. 15(11). 1666–1672. 102 indexed citations
19.
Crowe, Andrew & Evan H. Morgan. (1997). Effect of Dietary Cadmium on Iron Metabolism in Growing Rats. Toxicology and Applied Pharmacology. 145(1). 136–146. 39 indexed citations
20.
Crowe, Andrew & Evan H. Morgan. (1996). The effects of iron loading and iron deficiency on the tissue uptake of 64Cu during development in the rat. Biochimica et Biophysica Acta (BBA) - General Subjects. 1291(1). 53–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. M. Weinshilboum Breakdown of academic impact, for papers by Hideyuki Motohashi Breakdown of academic impact, for papers by Marvin B. Cohen Breakdown of academic impact, for papers by Donna J. Buckley Breakdown of academic impact, for papers by Petra Arndt Breakdown of academic impact, for papers by Lori A. Plum Breakdown of academic impact, for papers by Cathal McCarthy Breakdown of academic impact, for papers by Alessandro Fulgenzi Breakdown of academic impact, for papers by Ofer Spiegelstein Breakdown of academic impact, for papers by Francesc González‐Sastre
Rankless by CCL
2026